In vitro cationic lipid-mediated gene delivery with fluorinated glycerophosphoethanolamine helper lipids

被引:34
作者
Gaucheron, J
Boulanger, C
Santaella, C
Sbirrazzuoli, N
Boussif, O
Vierling, P [1 ]
机构
[1] Univ Nice, CNRS, UMR 6001, Lab Thermodynam Expt, F-06108 Nice 2, France
[2] Univ Nice, CNRS, UMR 6001, Chim Bioorgan Lab, F-06108 Nice 2, France
[3] Transgene SA, F-67082 Strasbourg, France
关键词
D O I
10.1021/bc010033j
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
There is a need for the development of nonviral gene transfer systems with improved and original properties. "Fluorinated" lipoplexes are such candidates, as supported by the remarkably higher in vitro and in vivo transfection potency found for such fluorinated lipoplexes as compared with conventional ones or even With PEI-based polyplexes (Boussif, O., Gaucheron, J., Boulanger, C., Santaella, C., Kolbe, H. V. J., Vierling, P. (2001) Enhanced in vitro and in vivo cationic lipid-mediated gene delivery with a fluorinated glycerophosphoethanolamine helper lipid. J. Gene Med. 3, 109-114). Here, we describe the synthesis of fluorinated glycerophosphoethanolamines (F-PEs), close analogues of dioleoylphosphatidylethanolamine (DOPE), and report on their lipid helper properties vs that of DOPE, as in vitro gene transfer components of fluorinated lipoplexes based on pcTG90, DOGS (Transfectam), or DOTAP. To evaluate the contribution of the F-PEs to in vitro lipoplex-mediated gene transfer, we examined the effect of including the F-PEs in lipoplexes formulated with these cationic lipids (CL) for various CL:DOPE:F-PE molar ratios [1:(l-x):x with x = 0, 0.5 and 1; 1:(2 - y):y with y = 0, 1, 1. 5, and 2], and various N/P ratios (from 10 to 0.8, N = number of CL amines, P = number of DNA phosphates). Irrespective of the F-PE chemical structure, of the colipid F-PE:DOPE composition, and of the N/P ratio, comparable transfection levels to those of their respective control DOPE lipoplexes were most frequently obtained when using one of the F-PEs as colipid of DOGS, pcTG90, or DOTAP in place of part of or of all DOPE. However, a large proportion of DOGS-based lipoplexes were found to display a higher transfection efficiency when formulated with the F-PEs rather than with DOPE alone while the opposite tendency was evidenced for the DOTAP-based lipoplexes. The present work indicates that "fluorinated" lipoplexes formulated with fluorinated helper lipids and conventional cationic lipids are very attractive candidates for gene delivery. It confirms further that lipophobicity and restricted miscibility of the lipoplex lipids with the endogenous lipids does not preclude efficient gene transfer and expression. Their transfection potency is rather attributable to their unique lipophobic and hydrophobic character (resulting from the formulation of DNA with fluorinated lipids), thus preventing to some extent DNA from interactions with lipophilic and hydrophilic biocompounds, and from degradation.
引用
收藏
页码:949 / 963
页数:15
相关论文
共 37 条
[1]   CORRELATION BETWEEN PHYSICOCHEMICAL CHARACTERISTICS OF SYNTHETIC CATIONIC AMPHIPHILES AND THEIR DNA TRANSFECTION ABILITY [J].
AKAO, T ;
OSAKI, T ;
MITOMA, J ;
ITO, A ;
KUNITAKE, T .
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1991, 64 (12) :3677-3681
[2]  
Balasubramaniam RP, 1996, GENE THER, V3, P163
[3]   Structure of in-serum transfecting DNA-cationic lipid complexes [J].
Boukhnikachvili, T ;
AguerreChariol, O ;
Airiau, M ;
Lesieur, S ;
Ollivon, M ;
Vacus, J .
FEBS LETTERS, 1997, 409 (02) :188-194
[4]  
Boussif O, 1996, GENE THER, V3, P1074
[5]  
BOUSSIF O, 2001, IN PRESS J GENE MED
[6]  
BURTON DJ, 1966, TETRAHEDRON LETT, P5163
[7]   Synthesis, activity, and structure-activity relationship studies of novel cationic lipids for DNA transfer [J].
Byk, G ;
Dubertret, C ;
Escriou, V ;
Frederic, M ;
Jaslin, G ;
Rangara, R ;
Pitard, B ;
Crouzet, J ;
Wils, P ;
Schwartz, B ;
Scherman, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (02) :224-235
[8]   THE ROLE OF DIOLEOYL PHOSPHATIDYLETHANOLAMINE IN CATIONIC LIPOSOME-MEDIATED GENE-TRANSFER [J].
FARHOOD, H ;
SERBINA, N ;
HUANG, L .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1995, 1235 (02) :289-295
[9]  
FELGNER JH, 1994, J BIOL CHEM, V269, P2550
[10]   Nomenclature for synthetic gene delivery systems [J].
Felgner, PL ;
Barenholz, Y ;
Behr, JP ;
Cheng, SH ;
Cullis, P ;
Huang, L ;
Jessee, JA ;
Seymour, L ;
Szoka, F ;
Thierry, AR ;
Wagner, E ;
Wu, G .
HUMAN GENE THERAPY, 1997, 8 (05) :511-512